Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110,002,045
-
Total 13F shares
-
1,488,385
-
Share change
-
+493,992
-
Total reported value
-
$264,200
-
Price per share
-
$0.18
-
Number of holders
-
26
-
Value change
-
+$76,046
-
Number of buys
-
12
-
Number of sells
-
8
Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q1 2025
As of 31 Mar 2025,
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,488,385 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, Corient Private Wealth LLC, TWO SIGMA SECURITIES, LLC, CITIGROUP INC, Cypress Point Wealth Management, LLC, Sippican Capital Advisors, Vanguard Personalized Indexing Management, LLC, CITADEL ADVISORS LLC, Naviter Wealth, LLC, and HRT FINANCIAL LP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.